134
Participants
Start Date
December 22, 2008
Primary Completion Date
April 6, 2016
Study Completion Date
November 8, 2017
lenalidomide
25mg oral capsules continuous days 1-21 each of a 28 day cycle
Medical University of Vienna, Vienna
Universitair Ziekenhuis Leuven, Campus Gasthuisberg, Leuven
Debreceni Egyetem Orvos- es Egeszsegtudomanyi Centrum, Debrecen
University of Debrecen, DEOEC, Institute of Internal Medicine, Debrecen
Landeskrankenhaus Salzburg, Salzburg
Universitaetsklinik Innsbruck, Innsbruck
Kaposi Mor Oktato Korhaz, Kaposvár
AZ Sint-Jan AV Brugge, Bruges
UZ Gent, Ghent
Petz Aladar Megyei Oktato Korhaz,II. Belgyogyaszat, Győr
NYU School of Medicine, New York
University of Rochester Cancer Center, James P. Wilmot Cancer Center, Rochester
Hillman Cancer Institute at UPMC, Pittsburgh
Temple University School of Medicine, Philadelphia
Alvin and Lois Lapidus Cancer Institute Sinai Hospital of Baltimore, Baltimore
University of Virginia Cancer Center Clinical Trials Office, Charlottesville
Presbyterian Hospital, Charlotte
South Carolina Cancer Specialists, Hilton Head Island
Winship Cancer Institute of Emory University, Atlanta
Lake County Oncology and Hematology, The Villages
MD Anderson Cancer Center, Orlando Regional Healthcare, Orlando
Institut Bergonie, Bordeaux
Broward General Medical Center, Fort Lauderdale
Boca Raton Community Hospital, Inc., Research Dept., Boca Raton
Istanbul Universitesi Istanbul, Istanbul
Pasco Hernando Oncology Associates, PA, Brooksville
Rambam Medical Center, Haifa
Hospital Clinico Universitario de Salamanca, Salamanca
University of Tennessee Cancer Institute, Memphis
Institut de Cancerologie de la Loire, Saint Jean Priest En Jarez
Hospital Universitario La Fe, Valencia
Indiana University Cancer Center, Indianapolis
Rabin Medical Center, Petch Tikva
Hopital Robert Debre, Reims
Sheba Medical Center, Tel Litwinsky
Mayo Clinic, Rochester
Avera Cancer Institute, Sioux Falls
Loyola University Medical Center - Smith, Maywood
Northwestern University, Chicago
Washington University Siteman Cancer Center, St Louis
Ospedale Civile dello Spirito Santo, Pescara
Hopital Hautepierre, Strasbourg
Hopital Emile Muller, Mulhouse
University of Arkansas for Medical Sciences, Little Rock
Hopital Cochin, Paris
Institut Curie, Paris
Hopital Sud, CHU d'Amiens, Amiens
Universita Federico II di Napoli Nuovo Policlinico, Napoli
Tower Cancer Research Foundation, Los Angeles
Hadassah Medical Center, Jerusalem
UCSD Moores Cancer Center, La Jolla
Loma Linda University Medical Center, Loma Linda
Hopital Henri Mondor, Créteil
University Hospital Wuerzburg, Würzburg
Singapore General Hospital, Singapore
Tufts Medical Center, Boston
Beth Israel Deaconess Medical Center, Boston
University of Massachusetts Medical Center, Worcester
Karmanos Cancer Institute, Detroit
University of Nebraska, Omaha
Hackensack University Medical Center, Hackensack
Hospital Universitario San Ignacio, Bogotá
Oncologos del occidente S.A., Pereira
Universita Cattololica del Sacro Cuore, Roma
Centro De Cancer, Hospital Espanol Auxilio De Puerto Rico, San Juan
Hospital General De Elche, Alicante
Duran i Reynals Institut Catala d'Oncologia, L'Hospitalet de Llobregat
Gazi Universitesi, Besevler Ankara
Ankara Universitesi Tip Fakultesi, Sihhiye Ankara
Royal Cornwall Hospitals Trust, Truro
Lead Sponsor
Celgene
INDUSTRY